ENDOTHEIA INC
Next-generation flexible endoscopy devices
New patent ·
- Sector
- Medtech
- Headquarters
- Nashville, TN
- Latest Form D
- $500K, Sep 2024
- Total capital
- $11.7M
- Federal grants
- $11.2M
- 15 awards · 2019–2024
- Rank in peer group#153 of 538
- Private capital raised
- $500K
- 1 Form D · last Sep 2024
- 25 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 16 pending · first 2026
- Rank in peer group#190 of 538
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$500K
- Federal grantHealth and Human S · Phase II · Breaking the Scope Port Size Barrier: A New Kind of Endoscope that Removes Large Kidney Stones Rapidly$110K
- Federal grantHealth and Human S · Phase II · Breaking the Scope Port Size Barrier: A New Kind of Endoscope that Removes Large Kidney Stones Rapidly$919K
- Federal grantHealth and Human S · Phase II · Breaking the Scope Port Size Barrier: A New Kind of Endoscope that Removes Large Kidney Stones Rapidly$929K
- Federal grantHealth and Human S · Phase II · Breaking the Scope Port Size Barrier: A New Kind of Endoscope that Removes Large Kidney Stones Rapidly$929K
- Federal grantHealth and Human S · Phase II · Dexterity Enhancement for Flexible Endoscopic Interventional Tools$663K
- Federal grantHealth and Human S · Phase II · An Ultra-Thin Steerable Transnasal Endoscope to Replace Exploratory Middle Ear Surgeries$662K
Show 9 earlier federal awards
- Federal grantHealth and Human S · Phase II · Dexterity Enhancement for Flexible Endoscopic Interventional Tools$1.4M
- Federal grantHealth and Human S · Phase II · Dexterity Enhancement for Flexible Endoscopic Interventional Tools$725K
- Federal grantHealth and Human S · Phase II · An Ultra-Thin Steerable Transnasal Endoscope to Replace Exploratory Middle Ear Surgeries$1.4M
- Federal grantHealth and Human S · Phase II · An Ultra-Thin Steerable Transnasal Endoscope to Replace Exploratory Middle Ear Surgeries$722K
- Federal grantHealth and Human S · Phase II · Squashing the Scope Superbug: A Disposable System for ERCP that Saves Patients from Bacterial Cross-Contamination$540K
- Federal grantHealth and Human S · Phase II · Squashing the Scope Superbug: A Disposable System for ERCP that Saves Patients from Bacterial Cross-Contamination$1.2M
- Federal grantHealth and Human S · Phase II · Squashing the Scope Superbug: A Disposable System for ERCP that Saves Patients from Bacterial Cross-Contamination$618K
- Federal grantHealth and Human S · Phase I · Enabling dexterous surgery at the tip of a flexible endoscope: A low-cost, disposable, steerable sheath.$223K
- Federal grantHealth and Human S · Phase I · Enabling dexterous surgery at the tip of a flexible endoscope: A low-cost, disposable, steerable sheath.$223K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
62months
from ENDOTHEIA INC’s first federal award to its first private round.
- First federal award · Jul 2019
- Health and Human S · $223K
- First Form D · Sep 2024
- $500K · 1st Form D
- Awards before first raise
- 15 awards
An association in public records, not a cause or a prediction.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grants#153 · top 28%
- Granted patents#190 · top 35%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Joshua J. GaffordResearcherExecutive Officer, DirectorLinked by 1 patent · $4.9M in grants as PI
- Robert J. WebsterResearcherExecutive Officer, DirectorLinked by $223K in grants as PI
- Brandon Duke HoffmanDirectorNamed in SEC Form D filings
- Caleb Duke RuckerExecutive Officer, DirectorNamed in SEC Form D filings
- Sam Duke HelebaDirectorNamed in SEC Form D filings
- Scott J. WebsterExecutive Officer, DirectorNamed in SEC Form D filings
Show all 7 people
- S. Duke HerrellExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 18- New patentApparatuses And Methods For Endoscope Laser Fiber SteeringUSPTOUS 12,761,460
- GrantedMethod And Apparatus For EndoscopyUSPTOUS 12,533,016
- PendingApparatuses and Methods for a Tubular Concentric Tube Continuum ManipulatorUSPTOApplication 19250804
Show all 18 patent records
- Apparatuses And Methods For Endoscope Laser Fiber SteeringOct 13, 2026 · US 12,761,460Granted
- Method And Apparatus For EndoscopyJan 27, 2026 · US 12,533,016Granted
- Apparatuses and Methods for a Tubular Concentric Tube Continuum ManipulatorJan 1, 2026 · Application 19250804Pending
- Apparatuses And Methods For Endoscope Laser Fiber SteeringDec 4, 2025 · Application 19219806Pending
- Side-viewing Endoscope CapOct 9, 2025 · Application 19169823Pending
- Method and Device for Endoscopic AspirationJun 20, 2024 · Application 18082435Pending
- Method And Apparatus For Endoscopic Stone RetrievalMay 2, 2024 · Application 18238258Pending
- Method And Apparatus For EndoscopyApplication PCTUS2023072920Pending
- Method And Apparatus For Endoscopic Stone RetrievalApplication PCTUS2023072927Pending
- Method And Apparatus For Otologic EndoscopyApplication 63419836Pending
- Method And Apparatus For Endoscopic Stone RetrievalApplication 63419842Pending
- Method And Device For Endoscopic AspirationApplication PCTUS2023084243Pending
- Apparatuses And Methods For A Tubular Concentric Tube Continuum ManipulatorApplication PCTUS2025035456Pending
- Apparatuses And Methods For Endoscope Laser Fiber SteeringApplication PCTUS2025031031Pending
- Side-viewing Endoscope CapApplication PCTUS2025023048Pending
- Apparatuses And Methods For A Tubular Concentric Tube Continuum ManipulatorApplication 63664717Pending
- Apparatuses And Methods For Endoscope Laser Fiber SteeringApplication 63651972Pending
- Side-viewing Endoscope CapApplication 63574673Pending
Related companies, and why
- VIRTUOSO SURGICAL, INC.Shares a founder: ROBERT WEBSTER
- PROTEAS BIOANALYTICS INC.Similar federal contract value in Medtech · null in contracts
- GATEWAY BIOTECHNOLOGY, INC.Similar federal contract value in Medtech · null in contracts
- MicroStructure Imaging, Inc.Similar federal contract value in Medtech · null in contracts
- GYNION, LLCSimilar federal contract value in Medtech · null in contracts
- SCIKON INNOVATION, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .